Final-Program-ATS-2023-AP.vp

46

SUNDAY • MAY 21

10:48 Breakdown of the Apical Spectrin Network Leads to Endothelial Dysfunction and Vascular Stiffening in Pulmonary Arterial Hypertension/ S. Sulstarova, Toronto, Canada

BASIC • TRANSLATIONAL MINI SYMPOSIUM

A16

INTERROGATING GENOMIC, TRANSCRIPTIONAL, AND EPIGENETIC MECHANISMS IN LUNG FIBROSIS

BEHAVIORAL • CLINICAL • TRANSLATIONAL MINI SYMPOSIUM

9:00 a.m. - 11:00 a.m.

Marriott Marquis Downtown Independence Ballroom Salons A-D (Level M4)

A15

TAKING PULMONARY REHABILITATION TO THE NEXT LEVEL

Chairing: M. Rojas, MD, Columbus, OH

O. Eickelberg, MD, ATSF, Pittsburgh, PA E.F. Redente, PhD, Denver, CO

9:00 a.m. - 11:00 a.m.

Walter E. Washington Convention Center Room 150 A-B (Street Level)

Featured Speaker: 9:00 Dynamics of Fibroblast Heterogeneity in Pulmonary Fibrosis/ D. Sheppard, San Francisco, CA Oral Presentations: 9:12 Genome-wide Screens Identify an Intracellular Rheostat Controlling Collagen Turnover/ M. Podolsky, New York, NY 9:24 Profiling Chromatin Accessibility and Gene Expression From the Same Nucleus to Expose Regulators of Human Lung Cell Identity/ T.E.A. Duong, San Diego, CA 9:36 Using Single Nuclei Multiomics and Spatial Transcriptomics to Identify Drivers of Early Pulmonary Fibrosis/ N. Banovich, Phoenix, AZ 9:48 Genetically-informed Single-cell Genomic Analysis of Discordantly Affected Regions of IPF Lungs/ J. Kropski, Nashville, TN 10:00 Spatial Transcriptomic Analysis Allow the Identification of Abnormal Airway Niches in the Fibrotic Lung/ A. Justet, New Haven, CT 10:12 Multiomic Single-nucleus Sequencing Implicates RUNX Family Transcription Factors in Activated Myofibroblast Differentiation in SSc-ILD/ E. Valenzi, Pittsburgh, PA 10:24 Resolving Age-dependent Cellular Senescence Programs in Lung Fibrosis Using Longitudinal Single Cell Transcriptomics/ M. Lehmann, Marburg, Germany 10:36 Somatic Mutations of MUC5B Within Lung Tissue in Idiopathic Pulmonary Fibrosis/ J.H. Yun, Boston, MA 10:48 Investigating the Role of YAP/TrkB Signaling in Lung Capillary Endothelial Cell Regeneration and Fibrosis Resolution/ A.A. Raslan, Boston, MA

Chairing: F. Franssen, MD, PhD, Horn, Netherlands S.J. Singh, PhD, Leicester, United Kingdom Oral Presentations: 9:00 Improving Depression in COPD Patients Through Home-based Pulmonary Rehabilitation With Health Coaching/ R. Benzo, Rochester, MN 9:12 Pulmonary Rehabilitation With Balance Training for Fall Reduction in Chronic Obstructive Pulmonary Disease: A Randomized Controlled Trial/ Q. Hao, Hamilton, Canada 9:24 Association Between Muscle Oxidative Capacity and Mortality in Humans With and Without COPD/ A. Adami, Kingston, RI 9:36 Telerehabilitation Vs. Centre-based Pulmonary Rehabilitation: An Economic Analysis/ A. Burge, Melbourne, Australia 9:48 High-Pressure Non-Invasive Ventilation (NIV) During Exercise Training in COPD Patients With Chronic Hypercapnic Respiratory Failure (CHRF) - Effects on Quality of Life and People’s Perception. A Randomized Controlled Trial/ T. Schneeberger, Schoenau am Koenigssee, Germany 10:00 Screening for Clinically Relevant Thresholds of the Incremental Shuttle Walk in People With COPD Using the One-minute Sit to Stand/ S. Patel, London, United Kingdom Rehabilitation Programs for Pulmonary Hypertension/ N. Morris, Gold Coast, Australia 10:24 Video Telerehabilitation Versus Centre-based Pulmonary Rehabilitation: A Real-World Propensity Matched Analysis/ W. Man, Harefield, United Kingdom 10:36 Self-Efficacy Enhancing Intervention Increases Physical Activity in People With Chronic Obstructive Pulmonary Disease/ J.L. Larson, Ann Arbor, MI 10:12 Updated Cochrane Review: Exercise-based

ATS 2023 • Washington, DC